Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous versus intramuscular oxytocin for prevention of atonic primary postpartum haemorrhage
PACTR201902721929705Completed
- Sponsor
- Nnamdi Azikiwe University Teaching Hospital
- Start
- Feb 2019
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial of oxytocin in postpartum hemorrhage (PPH) (2 arms), sponsored by Nnamdi Azikiwe University Teaching Hospital. Primary endpoints: Mean postpartum blood loss and Maternal hypotension. Started Feb 2019; status: completed.
02
Drugs
oxytocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on PACTR201902721929705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201902721929705.